NCT00544557View on ClinicalTrials.gov

Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis

CompletedOBSERVATIONAL
Enrollment

1,715

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Etanercept

The patients will be treated in accordance with the requirements of the labeling of etanercept in Germany. The dosage and duration of therapy is to be determined by the physician to meet the patients' individual needs for treatment.

Trial Locations (1)

12200

Klinikum Benjamin Franklin, Berlin

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY